Sebastian Meltzer

595 total citations
34 papers, 372 citations indexed

About

Sebastian Meltzer is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Sebastian Meltzer has authored 34 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 14 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Sebastian Meltzer's work include Colorectal Cancer Surgical Treatments (10 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Sebastian Meltzer is often cited by papers focused on Colorectal Cancer Surgical Treatments (10 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Sebastian Meltzer collaborates with scholars based in Norway, Denmark and Sweden. Sebastian Meltzer's co-authors include Anne Hansen Ree, Kathrine Røe Redalen, Kjersti Flatmark, Svein Dueland, Erta Kalanxhi, Caroline Jegerschöld, Anne Negård, Therese Seierstad, Lars Gustav Lyckander and Knut Håkon Hole and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Sebastian Meltzer

30 papers receiving 370 citations

Peers

Countries citing papers authored by Sebastian Meltzer

Since Specialization

Citations

This map shows the geographic impact of Sebastian Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Meltzer more than expected).

Fields of papers citing papers by Sebastian Meltzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Meltzer. The network helps show where Sebastian Meltzer may publish in the future.

Co-authorship network of co-authors of Sebastian Meltzer

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Meltzer. A scholar is included among the top collaborators of Sebastian Meltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Meltzer. Sebastian Meltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial 2026 ·Acta Oncologica ·(unknown), (unknown), Ragnhild Sørum Falk, (unknown), (unknown), Pitt Niehusmann, (unknown), (unknown), (unknown), (unknown), Sebastian Meltzer, (unknown), (unknown), (unknown), Sigbjørn Smeland, (unknown), (unknown), (unknown)	0
2	Quantitative MRI-based radiomics analysis identifies blood flow feature associated to overall survival for rectal cancer patients 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Anne Negård, (unknown), Anne Hansen Ree, Sebastian Meltzer, Alberto Traverso, Kathrine Røe Redalen	5
3	First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer—the randomised METIMMOX trial 2024 ·British Journal of Cancer ·Anne Hansen Ree, Jūratė Šaltytė Benth, Hanne Hamre, Christian Kersten, Eva Hofsli, Marianne G. Guren, Halfdan Sørbye, (unknown), Anne Negård, (unknown), Hilde Nilsen, Jens Petter Berg, Kjersti Flatmark, Sebastian Meltzer	11
4	IMPRESS-Norway: Improving public cancer care by implementing precision cancer medicine in Norway. 2023 ·Journal of Clinical Oncology ·Åslaug Helland, Sigbjørn Smeland, Hege G. Russnes, (unknown), (unknown), Pitt Niehusmann, Marte Grønlie Cameron, Egil Støre Blix, (unknown), (unknown), Daniel Heinrich, Sebastian Meltzer, Åsmund Flobak, (unknown), (unknown), (unknown), Astrid Dalhaug, Geir Olav Hjortland, Line Bjørge, Kjetil Taskén	0
5	Next-generation sequencing reveals mitogenome diversity in plasma extracellular vesicles from colorectal cancer patients 2023 ·BMC Cancer ·(unknown), (unknown), Kathrine Røe Redalen, Anne‐Marie Siebke Trøseid, Torben Lüders, Espen Stang, (unknown), (unknown), (unknown), Christian Kersten, Sebastian Meltzer, Anne Hansen Ree	3
6	Energy Metabolism Is Altered in Radioresistant Rectal Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), Xiaofei Yin, Sebastian Meltzer, Anne Hansen Ree, Kathrine Røe Redalen, Lorraine Brennan, Jacintha O’Sullivan, Niamh Lynam‐Lennon	3
7	Imaging the tumour microenvironment in rectal cancer: Decline in tumour blood flow during radiotherapy predicts good outcome 2023 ·Physics and Imaging in Radiation Oncology ·(unknown), Sebastian Meltzer, Endre Grøvik, Anne Negård, (unknown), (unknown), (unknown), Lars Gustav Lyckander, (unknown), Atle Bjørnerud, (unknown), Anne Hansen Ree, Kathrine Røe Redalen	2
8	Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer 2022 ·British Journal of Cancer ·Sebastian Meltzer, Anne Negård, (unknown), Hanne Hamre, Christian Kersten, Eva Hofsli, Marianne G. Guren, Halfdan Sørbye, Kjersti Flatmark, Anne Hansen Ree	5
9	Semi-automatic tumor segmentation of rectal cancer based on functional magnetic resonance imaging 2022 ·Physics and Imaging in Radiation Oncology ·(unknown), (unknown), (unknown), Turid Torheim, Anne Negård, (unknown), (unknown), Sebastian Meltzer, Cecilia Marie Futsæther, Kathrine Røe Redalen	3
10	The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression 2021 ·Clinical & Translational Oncology ·(unknown), Sebastian Meltzer, (unknown), Torben Lüders, Ying Esbensen, (unknown), Christoffer Johansen, Lars Gustav Lyckander, (unknown), Else Marit Inderberg, Christian Kersten, Kathrine Røe Redalen, Anne Hansen Ree	4
11	The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer 2021 ·British Journal of Cancer ·Sebastian Meltzer, (unknown), (unknown), (unknown), Kjersti Flatmark, Svein Dueland, (unknown), (unknown), Anne Negård, (unknown), Lars Gustav Lyckander, Finn Ole Larsen, Jakob Vasehus Schou, Kathrine Røe Redalen, Anne Hansen Ree	8
12	Sex Differences and Tumor Blood Flow from Dynamic Susceptibility Contrast MRI Are Associated with Treatment Response after Chemoradiation and Long-term Survival in Rectal Cancer 2020 ·Radiology ·(unknown), Sebastian Meltzer, Endre Grøvik, Anne Negård, (unknown), (unknown), Atle Bjørnerud, Anne Hansen Ree, Kathrine Røe Redalen	14
13	Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast‐based MRI in rectal cancer 2019 ·Journal of Magnetic Resonance Imaging ·(unknown), Endre Grøvik, Sebastian Meltzer, Anne Negård, (unknown), (unknown), Lars Gustav Lyckander, Anne Hansen Ree, (unknown), Kathrine Røe Redalen, Atle Bjørnerud	11
14	Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors? 2019 ·Clinical and Translational Radiation Oncology ·Sebastian Meltzer, (unknown), (unknown), Anne Negård, Kjersti Flatmark, (unknown), (unknown), (unknown), Christian Kersten, Svein Dueland, Therese Seierstad, Knut Håkon Hole, Lars Gustav Lyckander, Finn Ole Larsen, Jakob Vasehus Schou, (unknown), (unknown), Kathrine Røe Redalen, Anne Hansen Ree	8
15	Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer 2019 ·Cancer Immunology Immunotherapy ·(unknown), (unknown), Kjersti Flatmark, Svein Dueland, Knut Håkon Hole, Therese Seierstad, Kathrine Røe Redalen, Sebastian Meltzer, Anne Hansen Ree	40
16	High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer 2019 ·BMC Cancer ·(unknown), Alina Carmen Porojnicu, Jonas Christoffer Lindstrøm, Svein Dueland, Kjersti Flatmark, Knut Håkon Hole, Therese Seierstad, Johan Moan, Kathrine Røe Redalen, Sebastian Meltzer, Anne Hansen Ree	10
17	Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer 2018 ·Translational Oncology ·(unknown), Sebastian Meltzer, (unknown), Ying Esbensen, Svein Dueland, Kjersti Flatmark, Beathe Sitter, Tone F. Bathen, Therese Seierstad, Kathrine Røe Redalen, Lars Eide, Anne Hansen Ree	16
18	Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer 2018 ·British Journal of Cancer ·Erta Kalanxhi, Sebastian Meltzer, Jakob Vasehus Schou, Finn Ole Larsen, Svein Dueland, Kjersti Flatmark, Benny Vittrup Jensen, Knut Håkon Hole, Therese Seierstad, Kathrine Røe Redalen, Dorte Nielsen, Anne Hansen Ree	25
19	Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening 2016 ·BMC Cancer ·Erta Kalanxhi, (unknown), Sebastian Meltzer, Svein Dueland, Kjersti Flatmark, Anne Hansen Ree	7
20	Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks 2014 ·International Journal of Molecular Sciences ·Anne Hansen Ree, Sebastian Meltzer, Kjersti Flatmark, Svein Dueland, Erta Kalanxhi	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact